BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cheng HY, Lin HC, Lin HL, Uang YS, Keller JJ, Wang LH. Association Between Nonselective Beta-Blocker Use and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Without Cirrhosis and Decompensation. Front Pharmacol 2021;12:805318. [PMID: 35069216 DOI: 10.3389/fphar.2021.805318] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Sauerbruch T, Hennenberg M, Trebicka J, Schierwagen R. Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection? Front Med 2023;9. [DOI: 10.3389/fmed.2022.1100966] [Reference Citation Analysis]
2 Altshuler E, Aryan M, Kallumkal G, Gao H, Wilson J, Ouni A, De Leo E, Hanayneh W, Pan K. Impact of β-blockers on survival outcomes in patients with unresectable hepatocellular carcinoma. Hepatic Oncology 2022;9:HEP43. [DOI: 10.2217/hep-2021-0010] [Reference Citation Analysis]